ArticleFrontiers in pharmacology2018

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

Fernanda F Peres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.